Literature DB >> 31663643

The emerging importance of tranexamic acid in dermatology.

E Forbat1, F Al-Niaimi2, F R Ali2.   

Abstract

Tranexamic acid (TA) is an antifibrinolytic agent, increasingly recognized as being of utility for a wide variety of skin diseases. We review the evidence supporting the use of TA for a range of dermatological indications, including (among others) melasma, postinflammatory hyperpigmentation, urticaria, angio-oedema and haemostasis, in addition to practical considerations of its use by dermatologists.
© 2019 British Association of Dermatologists.

Entities:  

Year:  2019        PMID: 31663643     DOI: 10.1111/ced.14115

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

1.  Facelift Patients Receiving Intraoperative Administration of a Self-assembling Hemostat Agent Experienced Minimal Bruising and No Acute Hematomas: A Pilot Study.

Authors:  Julius Few
Journal:  Aesthet Surg J Open Forum       Date:  2022-04-29

2.  Collagenase Clostridium histolyticum for the Treatment of Cellulite in the Buttocks and Thigh: Early Insights From Clinical Practice.

Authors:  Miles Graivier; David Hill; Bruce Katz; Kristin A Boehm; Juliya Fisher; China Battista
Journal:  Aesthet Surg J Open Forum       Date:  2022-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.